The association between soluble suppression of tumorigenicity-2 and low-density lipoproteins level in patients with coronary heart disease and type 2 diabetes mellitus

Background and Aims: It is known that high soluble suppression of tumorigenicity-2 (sST2) is a marker of unfavorable course coronary heart disease (CHD) however, relationship between lipid metabolism parameters and novel biomarkers in patients with CHD and type 2 diabetes mellitus (T2DM) not researched. Aim: to investigate the association between sST2, NTproBNP and low-density lipoproteins (LDL) level in patients with CHD and T2DM.